» Articles » PMID: 7708013

The Human Immunodeficiency Virus Type 1 (HIV-1) CD4 Receptor and Its Central Role in Promotion of HIV-1 Infection

Overview
Journal Microbiol Rev
Specialty Microbiology
Date 1995 Mar 1
PMID 7708013
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Interactions between the viral envelope glycoprotein gp120 and the cell surface receptor CD4 are responsible for the entry of human immunodeficiency virus type 1 (HIV-1) into host cells in the vast majority of cases. HIV-1 replication is commonly followed by the disappearance or receptor downmodulation of cell surface CD4. This potentially renders cells nonsusceptible to subsequent infection by HIV-1, as well as by other viruses that use CD4 as a portal of entry. Disappearance of CD4 from the cell surface is mediated by several different viral proteins that act at various stages through the course of the viral life cycle, and it occurs in T-cell lines, peripheral blood CD4+ lymphocytes, and monocytes of both primary and cell line origin. At the cell surface, gp120 itself and in the form of antigen-antibody complexes can trigger cellular pathways leading to CD4 internalization. Intracellularly, the mechanisms leading to CD4 downmodulation by HIV-1 are multiple and complex; these include degradation of CD4 by Vpu, formation of intracellular complexes between CD4 and the envelope precursor gp160, and internalization by the Nef protein. Each of the above doubtless contributes to the ultimate depletion of cell surface CD4, although the relative contribution of each mechanism and the manner in which they interact remain to be definitively established.

Citing Articles

Stronger binding affinities of in provide insights into HIV/host interactions.

Li V, Lee C, Park T, Jarvis E, Kim H Infect Dis Model. 2024; 10(1):287-301.

PMID: 39620069 PMC: 11607582. DOI: 10.1016/j.idm.2024.10.003.


Development of Anti-HIV Therapeutics: From Conventional Drug Discovery to Cutting-Edge Technology.

Sun Y, Wang L Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065738 PMC: 11280173. DOI: 10.3390/ph17070887.


HIV-Related Oral Mucosa Lesions: A Cross-Sectional Study on a Cohort of Italian Patients.

Tarozzi M, Baruzzi E, Decani S, Tincati C, Santoro A, Moneghini L Biomedicines. 2024; 12(2).

PMID: 38398038 PMC: 10886531. DOI: 10.3390/biomedicines12020436.


Electrostatic Surface Potential as a Key Parameter in Virus Transmission and Evolution: How to Manage Future Virus Pandemics in the Post-COVID-19 Era.

Fantini J, Azzaz F, Chahinian H, Yahi N Viruses. 2023; 15(2).

PMID: 36851498 PMC: 9964723. DOI: 10.3390/v15020284.


Implications of RNA Viruses in the Male Reproductive Tract: An Outlook on SARS-CoV-2.

Zafar M, Yu J, Li H Front Microbiol. 2022; 12:783963.

PMID: 35003013 PMC: 8739959. DOI: 10.3389/fmicb.2021.783963.


References
1.
Sleckman B, Shin J, Igras V, Collins T, Strominger J, Burakoff S . Disruption of the CD4-p56lck complex is required for rapid internalization of CD4. Proc Natl Acad Sci U S A. 1992; 89(16):7566-70. PMC: 49751. DOI: 10.1073/pnas.89.16.7566. View

2.
Gavalchin J, Fan N, Lane M, Papsidero L, Poiesz B . Identification of a putative cellular receptor for HTLV-I by a monoclonal antibody, Mab 34-23. Virology. 1993; 194(1):1-9. DOI: 10.1006/viro.1993.1228. View

3.
Bandres J, Ratner L . Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation. J Virol. 1994; 68(5):3243-9. PMC: 236815. DOI: 10.1128/JVI.68.5.3243-3249.1994. View

4.
Nada S, Yagi T, Takeda H, Tokunaga T, Nakagawa H, Ikawa Y . Constitutive activation of Src family kinases in mouse embryos that lack Csk. Cell. 1993; 73(6):1125-35. DOI: 10.1016/0092-8674(93)90642-4. View

5.
Glaichenhaus N, Shastri N, Littman D, Turner J . Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell. 1991; 64(3):511-20. DOI: 10.1016/0092-8674(91)90235-q. View